JOANNA SILVA: Open Payments
NPI 1023682861 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 15 payments from 9 companies in 2025. Trend: 2023 $297 · 2024 $154 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $34 |
| Novo Nordisk Inc | 2 | $33 |
| Smith+Nephew, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Korlym, REXULTI, Renasys, ZEPBOUND, Auvelity, Rybelsus, Tymlos, ZENPEP.
Industry payments across TX — which companies pay providers there.
